Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Arcutis Biotherapeutics, Inc. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ARQT
Nasdaq
2830
www.arcutis.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Arcutis Biotherapeutics, Inc.
Arcutis Biotherapeutics (ARQT) Stock Looks Expensive Despite Its Huge Three Year Run
- Nov 13th, 2026 6:16 pm
Arcutis Presents New Caregiver-Reported Outcomes Data Supporting ZORYVE® (roflumilast) Cream 0.05% for Mild to Moderate Atopic Dermatitis in Infants Down to 3 Months at the ACAAI Annual Scientific Meeting
- Nov 13th, 2026 7:00 am
Arcutis Biotherapeutics Inc (ARQT) (Q3 2026) Earnings Call Highlights: Revenue Surges 45% to ...
- Nov 7th, 2026 4:08 pm
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Nov 6th, 2026 2:00 pm
Arcutis Biotherapeutics (ARQT) Raised 2026 Sales Guidance, Is The Upside Already Priced In?
- Nov 6th, 2026 3:14 am
Biotech Earnings: Who Won, Who Lost And Who Pulled Off A 'Historic' Launch?
- Nov 5th, 2026 2:22 pm
Arcutis Biotherapeutics, Inc. Q3 2026 Earnings Call Summary
- Nov 5th, 2026 6:30 am
Arcutis Begins Enrolling Phase 3 Study Evaluating ZORYVE® (roflumilast) Cream 0.3% in Moderate to Severe Atopic Dermatitis
- Nov 5th, 2026 6:00 am
Arcutis Biotherapeutics Q3 Earnings Call Highlights
- Nov 4th, 2026 5:14 pm
Arcutis Biotherapeutics, Inc. (ARQT) Misses Q3 Earnings Estimates
- Nov 4th, 2026 2:15 pm
Arcutis Announces Third Quarter 2026 Financial Results and Provides Business Update
- Nov 4th, 2026 2:00 pm
Sarepta Therapeutics (SRPT) Earnings Expected to Grow: Should You Buy?
- Oct 29th, 2026 7:00 am
Arcutis Biotherapeutics, Inc. (ARQT) Reports Next Week: Wall Street Expects Earnings Growth
- Oct 28th, 2026 7:00 am
Arcutis Appoints Rob Scott, MD to Board of Directors
- Oct 28th, 2026 7:00 am
Arcutis Management to Present at the Guggenheim 3rd Annual Healthcare Innovation Conference
- Oct 27th, 2026 2:00 pm
Arcutis to Report Third Quarter 2026 Financial Results and Host Conference Call on November 4, 2026
- Oct 21st, 2026 2:00 pm
Arcutis Biotherapeutics (ARQT) Gets New Rating Uprgades from 2 Analysts; Shares Climb
- Oct 19th, 2026 8:37 pm
Clinical Data Update Could Shape The Case For Arcutis Biotherapeutics Stock
- Oct 19th, 2026 5:21 pm
Arcutis Soars 12% as Guggenheim Lifts Target to $44 on “Growing Conviction” in 2027
- Oct 19th, 2026 11:13 am
2 Stocks That Could Soar in Q4
- Oct 12th, 2026 5:05 am
Scroll